CGRP Antagonist: New Hope for Abdominal Migraine in Kids

Research Summary

In a recent case report published in Headache, researchers explored the treatment of abdominal migraine in an 8-year-old using a calcitonin gene-related peptide (CGRP) receptor antagonist. This study highlights a novel approach for managing this rare migraine variant in children. The authors detail the successful use of a CGRP receptor antagonist, which is typically employed in adult migraine treatment, showing promising results in reducing the child's abdominal migraine symptoms. While this report focuses on a single case, it opens the door for further research into CGRP antagonists as a potential treatment option for pediatric abdominal migraines.

Study Details

📄 Title: Treatment of abdominal migraine in an 8-year-old child with calcitonin gene-related peptide receptor antagonist: A case report.

👥 Research Team: Tang Y et al.

📚 Published In: Headache

📅 Publication Date: 2025 Dec 10

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.